Open-source automated insulin delivery in type 1 diabetes—the evidence is out there-Reference-Cited by-同舟云学术

Open-source automated insulin delivery in type 1 diabetes—the evidence is out there

Published:2022-12 Issue:12 Volume:10 Page:835-836
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Hussain Sufyan,Lal Rayhan A,Braune Katarina

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference10 articles.

1. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals;Braune;Lancet Diabetes Endocrinol,2022

2. Consensus recommendations for the use of automated insulin delivery (AID) technologies in clinical practice;Phillip;Endocr Rev,2022

3. Do-it-yourself automated insulin delivery: a leading example of the democratization of medicine;Burnside;J Diabetes Sci Technol,2020

4. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: a systematic review;Knoll;Diabet Med,2022

5. Continuous glucose monitoring: data management and evaluation by patients and health care professionals—current situation and developments;Freckmann;J Lab Med,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open-Source-AID-Systeme (AID: automatische Insulindosierung) bei Kindern und Jugendlichen;Die Diabetologie;2024-08-12

2. Positionspapier: Open-source-Technologie in der Behandlung von Menschen mit Diabetes mellitus – eine österreichische Perspektive;Wiener klinische Wochenschrift;2024-07

3. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management;Diabetes Technology & Therapeutics;2024-05-13

4. Changes in ambulatory glucose profile in people with type 1 diabetes using an automated insulin delivery system - two year follow-up retrospective analysis of real-world data;Diabetes Epidemiology and Management;2023-07

5. The First Regulatory Clearance of an Open-Source Automated Insulin Delivery Algorithm;Journal of Diabetes Science and Technology;2023-04-13